8-K - Dermata Therapeutics, Inc. (0001853816) (Filer)
Dermata Therapeutics, Inc.（CIK 0001853816）于 2026-10-29 向 SEC 提交 8-K 表格，报告日期为 2026-10-29，文件列示 Item 8.01（其他事件）。该文件包含 11 份文档，公司地址为加州圣迭戈 Del Mar Heights 路 3525 号 #322，SIC 分类为 2834 药品制剂。
报错 · 内容有误？请告诉我们。
Filing Date
2026-10-29
Accepted
2026-10-29 17:26:36
Documents
11
Period of Report
2026-10-29
Items
Item 8.01: Other Events
Document Format Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 1 | 8-K | form8-k.htm iXBRL | 8-K | 37535 |
| Complete submission text file | 0001493152-26-049312.txt | 204352 |
Data Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 2 | XBRL SCHEMA FILE | drma-20261029.xsd | EX-101.SCH | 3017 |
| 3 | XBRL LABEL FILE | drma-20261029_lab.xml | EX-101.LAB | 34239 |
| 4 | XBRL PRESENTATION FILE | drma-20261029_pre.xml | EX-101.PRE | 22360 |
| 14 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 3340 |
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)
EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40739 | Film No.: 261502972
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)
来源：SEC EDGAR 8-K · sec.gov